Arrowhead Pharmaceuticals Ownership | Who Owns Arrowhead Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Arrowhead Pharmaceuticals Ownership Summary

Arrowhead Pharmaceuticals is owned by 76.97% institutional investors, 4.47% insiders, and 18.57% retail investors. Blackrock is the largest institutional shareholder, holding 12.72% of ARWR shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.21% of its assets in Arrowhead Pharmaceuticals shares.

ARWR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Arrowhead Pharmaceuticals	76.97%	4.47%	18.57%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	15.68M	12.72%	$407.61M
Vanguard group	12.21M	9.91%	$317.44M
Avoro capital advisors	8.89M	7.21%	$231.02M
Fmr	6.81M	5.53%	$177.05M
State street	5.84M	4.74%	$151.72M
Slate path capital lp	4.14M	3.36%	$107.57M
Geode capital management	2.94M	2.38%	$76.37M
T. rowe price investment management	2.56M	2.08%	$66.56M
Jpmorgan chase	2.32M	1.88%	$60.19M
Ubs asset management americas	2.29M	1.86%	$59.52M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aquilo capital management	908.47K	22.76%	$23.61M
Western financial corp/ca	820.24K	12.88%	$21.32M
Avoro capital advisors	8.89M	3.08%	$231.02M
M28 capital management lp	67.40K	2.27%	$1.75M
Slate path capital lp	4.14M	2.05%	$107.57M
Privium fund management b.v.	286.94K	1.85%	$7.24M
Johnson & johnson	247.60K	1.61%	$6.44M
Wealth effects	159.60K	1.50%	$4.15M
Hound partners	269.93K	1.41%	$7.02M
Artal group	1.00M	0.66%	$25.99M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	1.59M	0.01%	1.59M
Ubs asset management americas	2.29M	0.02%	1.36M
T. rowe price investment management	2.56M	0.04%	801.95K
Morgan stanley	1.82M	0.00%	679.41K
Jane street group	696.72K	0.00%	568.65K

Top Sellers

Holder	Shares	% Assets	Change
Rokos capital management llp	-	-	-939.98K
Orbimed advisors	-	-	-739.65K
State street	5.84M	0.01%	-722.94K
E. ohman j:or asset management ab	-	-	-714.21K
Pictet asset management sa	743.68K	0.02%	-482.30K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.59M	0.01%	1.59M	$41.20M
Squarepoint ops	383.83K	0.02%	383.83K	$9.98M
Hound partners	269.93K	1.41%	269.93K	$7.02M
Abrdn	248.67K	0.01%	248.67K	$6.46M
Mirae asset global etfs	231.54K	0.01%	231.54K	$6.02M

Sold Out

Holder	Change
Toronto dominion bank	-3.00
Financial gravity asset management	-4.00
Advisornet financial	-7.00
Innealta capital	-11.00
Riggs asset managment	-14.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	278	-1.77%	95,591,794	-2.21%	76	1.22%	124	-8.15%	89	7.23%
Jun 30, 2024	282	-1.40%	97,756,300	2.92%	79	1.34%	135	-7.53%	82	7.89%
Mar 31, 2024	286	1.06%	94,985,786	22.73%	77	1.48%	146	18.70%	76	-19.15%
Dec 31, 2023	283	9.69%	77,395,477	5.41%	72	1.54%	123	7.89%	94	-
Sep 30, 2023	258	-9.15%	73,421,452	1.59%	68	1.50%	114	-4.20%	94	-14.55%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Mid-Cap ETF	3.99M	3.21%	7.85K
Vanguard Total Stock Mkt Idx Inv	3.68M	2.96%	-26.71K
iShares Russell 2000 ETF	3.32M	2.67%	-6.93K
Vanguard Small Cap Index	2.96M	2.38%	5.80K
SPDR® S&P Biotech ETF	1.95M	1.57%	-59.22K
Vanguard Institutional Extnd Mkt Idx Tr	1.88M	1.51%	-7.13K
Vanguard Small Cap Growth Index Inv	1.63M	1.31%	-3.97K
Fidelity Growth Compy Commingled Pl S	1.29M	1.04%	80.27K
Fidelity Growth Compy Commingled Pl O	1.21M	0.98%	127.90K
Fidelity Small Cap Index	1.21M	0.97%	-9.03K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 16, 2024	Waddill William D.	-	Sell	$82.08K
Dec 17, 2024	Waddill William D.	-	Sell	$82.58K
Dec 17, 2024	GIVEN DOUGLAS B	-	Sell	$12.06K
Dec 16, 2024	GIVEN DOUGLAS B	-	Sell	$109.50K
Dec 16, 2024	Vakiener Victoria	-	Sell	$197.06K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	5
2024 Q3	-	1
2024 Q2	-	2
2024 Q1	3	37
2023 Q4	-	4

ARWR Ownership FAQ

Who Owns Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals shareholders are primarily institutional investors at 76.97%, followed by 4.47% insiders and 18.56% retail investors. The average institutional ownership in Arrowhead Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Arrowhead Pharmaceuticals exceeds.

Who owns the most shares of Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals’s largest shareholders are Blackrock (15.68M shares, 12.72%), Vanguard group (12.21M shares, 9.91%), and Avoro capital advisors (8.89M shares, 7.21%). Together, they hold 29.84% of Arrowhead Pharmaceuticals’s total shares outstanding.

Does Blackrock own Arrowhead Pharmaceuticals?

Yes, BlackRock owns 12.72% of Arrowhead Pharmaceuticals, totaling 15.68M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 407.61M$. In the last quarter, BlackRock increased its holdings by 336.57K shares, a 2.19% change.

Who is Arrowhead Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Aquilo capital management is Arrowhead Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 22.76% of its assets in 908.47K Arrowhead Pharmaceuticals shares, valued at 23.61M$.

Who is the top mutual fund holder of Arrowhead Pharmaceuticals shares?

iShares Core S&P Mid-Cap ETF is the top mutual fund holder of Arrowhead Pharmaceuticals shares, with 3.21% of its total shares outstanding invested in 3.99M Arrowhead Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools